Skip to main content

Advertisement

Fig. 4 | EJNMMI Research

Fig. 4

From: First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9

Fig. 4

Dosimetry comparison between our study and those of Roivainen et al. [30] and Zhang et al. [34] based on OLINDA/EXM 1.0. The absorbed dose estimations reported in this figure are based on either a 3.5-h urinary voiding cycle (our study and that of Roivainen et al. [30]) or on a 1-h voiding cycle (Zhang et al. [34]). It should be noted that, for the organs reported, variations of urinary voiding cycle do not produce significant changes of absorbed dose estimations. Error bars represent ± 2SD

Back to article page